Incyte CorporationINCYNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
5.98%
↓ 57% below average
Average (39q)
13.97%
Historical baseline
Range
High:246.88%
Low:-73.59%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 5.98% |
| Q2 2025 | 9.31% |
| Q1 2025 | -6.17% |
| Q4 2024 | -18.69% |
| Q3 2024 | -49.65% |
| Q2 2024 | 165.20% |
| Q1 2024 | -3.43% |
| Q4 2023 | 18.31% |
| Q3 2023 | -6.25% |
| Q2 2023 | -1.45% |
| Q1 2023 | -18.89% |
| Q4 2022 | 30.56% |
| Q3 2022 | 10.60% |
| Q2 2022 | -1.75% |
| Q1 2022 | -25.26% |
| Q4 2021 | 41.17% |
| Q3 2021 | -2.49% |
| Q2 2021 | 11.93% |
| Q1 2021 | -24.40% |
| Q4 2020 | -7.34% |
| Q3 2020 | 52.86% |
| Q2 2020 | -73.59% |
| Q1 2020 | 246.88% |
| Q4 2019 | 11.21% |
| Q3 2019 | -2.77% |
| Q2 2019 | 6.96% |
| Q1 2019 | -11.07% |
| Q4 2018 | 4.00% |
| Q3 2018 | -1.87% |
| Q2 2018 | -1.65% |
| Q1 2018 | -32.18% |
| Q4 2017 | 65.80% |
| Q3 2017 | 33.59% |
| Q2 2017 | -50.54% |
| Q1 2017 | 152.48% |
| Q4 2016 | 12.85% |
| Q3 2016 | 19.05% |
| Q2 2016 | -23.31% |
| Q1 2016 | 34.46% |
| Q4 2015 | -11.69% |